Evidence-based medicine in the treatment of peritoneal carcinomatosis: Past, present, and future

Aviram Nissan; Alexander Stojadinovic; Alfredo Garofalo; Jesus Esquivel; Pompiliu Piso

doi:10.1002/jso.21323

Evidence-based medicine in the treatment of peritoneal carcinomatosis: Past, present, and future

Aviram Nissan, Alexander Stojadinovic, Alfredo Garofalo, Jesus Esquivel, Pompiliu Piso

School of Medicine

Research output: Contribution to journal › Article › peer-review

30 Scopus citations

Abstract

The current treatment of peritoneal surface malignancies (PSMs) is moving from a nihilistic approach, into a combined modality approach offering selected patients long-term survival. As primary PSM are rare, extrapolation of data from clinical trials of related disease is necessary to develop treatment guidelines. Secondary PSM are more common, and therefore, treatment guidelines should be developed based on prospective clinical trials. We reviewed the published and ongoing clinical trials studying the treatment of PSM.

Original language	English (US)
Pages (from-to)	335-344
Number of pages	10
Journal	Journal of Surgical Oncology
Volume	100
Issue number	4
DOIs	https://doi.org/10.1002/jso.21323
State	Published - Sep 15 2009

Keywords

Carcinomatosis
Clinical trial
Cytoreduction
Hyperthermic chemotherapy
Peritoneal surface malignancies

ASJC Scopus subject areas

Surgery
Oncology

Access to Document

10.1002/jso.21323

Cite this

@article{f815718e7ab549a3be95dfe4592d734b,

title = "Evidence-based medicine in the treatment of peritoneal carcinomatosis: Past, present, and future",

abstract = "The current treatment of peritoneal surface malignancies (PSMs) is moving from a nihilistic approach, into a combined modality approach offering selected patients long-term survival. As primary PSM are rare, extrapolation of data from clinical trials of related disease is necessary to develop treatment guidelines. Secondary PSM are more common, and therefore, treatment guidelines should be developed based on prospective clinical trials. We reviewed the published and ongoing clinical trials studying the treatment of PSM.",

keywords = "Carcinomatosis, Clinical trial, Cytoreduction, Hyperthermic chemotherapy, Peritoneal surface malignancies",

author = "Aviram Nissan and Alexander Stojadinovic and Alfredo Garofalo and Jesus Esquivel and Pompiliu Piso",

year = "2009",

month = sep,

day = "15",

doi = "10.1002/jso.21323",

language = "English (US)",

volume = "100",

pages = "335--344",

journal = "Journal of Surgical Oncology",

issn = "0022-4790",

publisher = "Wiley-Liss Inc.",

number = "4",

}

TY - JOUR

T1 - Evidence-based medicine in the treatment of peritoneal carcinomatosis

T2 - Past, present, and future

AU - Nissan, Aviram

AU - Stojadinovic, Alexander

AU - Garofalo, Alfredo

AU - Esquivel, Jesus

AU - Piso, Pompiliu

PY - 2009/9/15

Y1 - 2009/9/15

N2 - The current treatment of peritoneal surface malignancies (PSMs) is moving from a nihilistic approach, into a combined modality approach offering selected patients long-term survival. As primary PSM are rare, extrapolation of data from clinical trials of related disease is necessary to develop treatment guidelines. Secondary PSM are more common, and therefore, treatment guidelines should be developed based on prospective clinical trials. We reviewed the published and ongoing clinical trials studying the treatment of PSM.

AB - The current treatment of peritoneal surface malignancies (PSMs) is moving from a nihilistic approach, into a combined modality approach offering selected patients long-term survival. As primary PSM are rare, extrapolation of data from clinical trials of related disease is necessary to develop treatment guidelines. Secondary PSM are more common, and therefore, treatment guidelines should be developed based on prospective clinical trials. We reviewed the published and ongoing clinical trials studying the treatment of PSM.

KW - Carcinomatosis

KW - Clinical trial

KW - Cytoreduction

KW - Hyperthermic chemotherapy

KW - Peritoneal surface malignancies

UR - http://www.scopus.com/inward/record.url?scp=69749097864&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69749097864&partnerID=8YFLogxK

U2 - 10.1002/jso.21323

DO - 10.1002/jso.21323

M3 - Article

C2 - 19697442

AN - SCOPUS:69749097864

SN - 0022-4790

VL - 100

SP - 335

EP - 344

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

IS - 4

ER -

Evidence-based medicine in the treatment of peritoneal carcinomatosis: Past, present, and future

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this